Analyst firms · Wolfe Research · CHWY
Wolfe Research CHWY price target and rating history
Chewy Inc. (CHWY) · Consumer Discretionary
Wolfe Research rates Chewy Inc. (CHWY) Outperform with a $90 price target, as of its latest action on Jan 3, 2025. It has published 4 rating actions on CHWY since September 2021, including 2 upgrades and 1 downgrade. Across 3 firms with a CHWY price target in the last 12 months, the median target is $25.
- Current rating
- Outperform
- Price target
- $90
- Median target, all firms
- $25
- Actions on CHWY
- 4
Every Wolfe Research rating on CHWY
- Jan 3, 2025
- Jul 16, 2024
- Dec 7, 2022
- Sep 28, 2021
How other firms rate CHWY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Evercore ISI | In-line | $25 | Sep 10, 2026 |
| Rosenblatt | Neutral | $25 | Aug 20, 2026 |
| MoffettNathanson | Neutral | Jun 11, 2026 | |
| Raymond James | Outperform | $28 | Feb 19, 2026 |
Questions about Wolfe Research and CHWY
- What is Wolfe Research's price target for CHWY?
- Wolfe Research's latest stated price target for Chewy Inc. (CHWY) is $90, from its action on Sep 28, 2021.
- What is Wolfe Research's rating on CHWY?
- Wolfe Research rates CHWY Outperform, a bullish rating, as of Jan 3, 2025.
- When did Wolfe Research last change its view on CHWY?
- On Jan 3, 2025, Wolfe Research upgrades to Outperform from Peer Perform.
- How does Wolfe Research's CHWY target compare with other analysts?
- Across 3 firms with a CHWY price target in the last 12 months, the median target is $25.
More CHWY rating histories
- Evercore ISI3
- MoffettNathanson3
- Raymond James3
- Deutsche Bank3
- Mizuho4
- Jefferies4
- Argus Research4
- BNP Paribas Exane3
- Citigroup3
- Needham4
- Piper Sandler4
- Barclays4
- Goldman Sachs4
- Morgan Stanley4
- UBS3
- Oppenheimer3
- Robert W. Baird3
- Wedbush5
All Wolfe Research ratingsCHWY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.